OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Drug Policy is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	139
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	101
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	93
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	73
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	71
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	68
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	65
Access to cannabidiol without a prescription: A cross-country comparison and analysis	60
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	58
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	58
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	55
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	53
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	53
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	52
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	52
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	50
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	49
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	48
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	47
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	46
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	46
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	45
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	45
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies	43
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	42

Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	42
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	41
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors	40
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking	40
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	40
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada	38
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects	38
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market	38
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants	37
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	37
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work	37
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	37